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ABSTRACT
Motivation: The Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) has recently emerged 
as the responsible for the pandemic outbreak of the coronavirus disease (COVID-19). This virus is closely 
related to coronaviruses infecting bats and Malayan pangolins, species suspected to be an intermediate 
host in the passage to humans. Several genomic mutations affecting viral proteins have been identified, 
contributing to the understanding of the recent animal-to-human transmission. However, the capacity of 
SARS-CoV-2 to encode functional putative microRNAs (miRNAs) remains largely unexplored. 
Results: We have used deep learning to discover 12 candidate stem-loop structures hidden in the viral 
protein-coding genome. Among the precursors, the expression of eight mature miRNAs-like sequences 
was confirmed in small RNA-seq data from SARS-CoV-2 infected human cells. Predicted miRNAs are likely 
to target a subset of human genes of which 109 are transcriptionally deregulated upon infection. 
Remarkably, 28 of those genes potentially targeted by SARS-CoV-2 miRNAs are down-regulated in 
infected human cells. Interestingly, most of them have been related to respiratory diseases and viral 
infection, including several afflictions previously associated with SARS-CoV-1 and SARS-CoV-2. The 
comparison of SARS-CoV-2 pre-miRNA sequences with those from bat and pangolin coronaviruses 
suggests that single nucleotide mutations could have helped its progenitors jumping inter-species 
boundaries, allowing the gain of novel mature miRNAs targeting human mRNAs. Our results suggest that 
the recent acquisition of novel miRNAs-like sequences in the SARS-CoV-2 genome may have contributed 
to modulate the transcriptional reprogramming of the new host upon infection.  
Contact: gstegmayer@sinc.unl.edu.ar
Supplementary information: Supplementary Data are available at Bioinformatics online.
1. INTRODUCTION
MicroRNAs (miRNAs) participate in post-
transcriptional gene regulation influencing diverse 
biological processes such as development, 
proliferation, cell differentiation and metabolism 
across different cell types [1,2,3]. Several miRNAs 
have been linked to the regulation of host-pathogen 
interactions including viral infection, controlling 
apoptosis, evasion of the immune response and 
modulation of the viral replication cycle [4,5,6]. Host 
miRNAs have been associated with antiviral 
defense mechanisms [7], whereas it has also been 
reported the production of miRNAs derived from 
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viral genomes, hinting at a complex crossed post-
transcriptional gene silencing interplay underlying 
the infection progression [8-10]. Most of the known 
viral miRNAs are encoded in genomes of either 
DNA viruses or RNA viruses with a nuclear stage, 
such as retroviruses, which can benefit from the 
nuclear host miRNA biogenesis machinery [11-13]. 
However, the production of functional miRNAs 
derived from cytoplasmic RNA viruses has also 
been observed [14,15]. In addition, the increasing 
sensitivity of deep sequencing technologies has 
also enabled the identification of other small viral 
non-coding RNAs from those RNA viruses [16]. 
Identifying both viral miRNAs and their targets in the 
human genome is of paramount importance, not 
only for understanding the molecular basis of the 
related disease but also for contributing to the 
identification of target molecules for the 
improvement of diagnostic and treatment strategies 
[17-20]. 
The Severe Acute Respiratory Syndrome-
Coronavirus 2 (SARS-COV-2), responsible for the 
recent pandemic outbreak of a novel coronavirus 
disease (COVID-19), is a positive-single stranded 
RNA virus with a genome of ~30 kb. It encodes 14 
open reading frames (ORFs) for producing up to 16 
non-structural proteins (Nsp1-16) and four 
structural proteins typical of several coronaviruses: 
Spike (S), Envelope (E), Membrane (M) and 
Nucleocapsid (N) [7,10]. Interestingly, using deep 
sequencing data and experimental validation it was 
shown that the SARS-CoV emerged in China in 
2002 encodes a group of small viral RNAs 
(svRNAs) functionally linked to the related lung 
pathogenesis [16]. However, the capacity of SARS-
CoV-2 to encode functional miRNA-like effectors 
and their potential impact in the human 
transcriptome remains largely unexplored. 
Here we used machine learning and a new deep 
learning model to identify miRNA-like precursors 
(pre-miRNAs) in the SARS-CoV-2 genome. Based 
on small RNA sequencing (RNA-seq) of infected 
epithelial cell cultures, we detected six of the 
identified pre-miRNAs potentially acting as 
precursors of eight mature miRNA-like molecules 
differentially accumulated during viral infection. 
Furthermore, analyzing bulk RNA-seq data of 
infected cell cultures we found deregulated 109 
predicted human targets, linked to the host immune 
response and viral infection. Twenty-eight of those 
targets, most of them involved in respiratory 
diseases and viral infection, were found as down-
regulated supporting the silencing effect of 
predicted mature miRNA-like molecules. We also 
performed a sequence comparison of pre-miRNAs 
with closely related coronaviruses. Strikingly, our 
results suggest that punctual recent mutations were 
responsible for the occurrence of the novel 
predicted mature miRNAs against human genes, 
thus potentially contributing to zoonotic transfer.
2. MATERIALS AND METHODS
2.1 DATA
Genome data of the virus were obtained from NCBI: 
Severe acute respiratory syndrome coronavirus 2 
isolate Wuhan-Hu-1, complete genome and its 
annotations (NCBI Reference Sequence 
NC_045512.2). In order to identify pre-miRNA 
sequences candidates, the SARS-CoV-2 genome 
was segmented with HextractoR [20a] into 600 nt 
long fragments with 500 nt overlaps, and the 
following parameters: single loop trimming, 
minimum sequence length 60, minimum number of 
base-pairs that must form a sequence 16 and final 
trimming optimizing the minimum free energy 
normalized by the sequence length (NMFE). These 
segments were folded into their secondary 
structures by using RNAfold [21] with default 
settings. Hairpin structures were extracted, 
obtaining 597 hairpins in total, which were 
considered as unlabeled samples. Pre-miRNA 
sequences of viruses, considered the positive 
labeled class, were downloaded from miRBase 
release 22.
Expression profiling by high throughput bulk RNA 
sequencing (RNA-seq) of the epithelial lung cancer 
cell line Calu-3 mock treated or infected with SARS-
CoV-2 (USA-WA1/2020) were obtained from NCBI: 
Gene expression profiling of SARS-CoV-1/2 
infected human cell lines at bulk and single-cell 
level (NCBI Reference series GSE148729), which 
was made public on May, 4th. Alignments files of 
small RNA-seq samples against SARS-CoV-1/2 
genomes were downloaded from authors repository 
(https://filetransfer.mdc-berlin.de/) and filtered for 
keeping only those reads aligned to the SARS-CoV-
2 genome.  
2.2 PREDICTION OF PRE-MIRNAS IN THE 
SARS-COV-2 GENOME 
A total of 73 structural features from the folded 
sequences of the virus genome and the well-known 
virus pre-miRNAs were extracted with miRNAfe [22] 
as in [23]. For example, features such as length of 
the sequence, minimum free energy (MFE), 
cumulative size of internal loops found in the 
secondary structure, number of loops, amount of 
GC, proportion of GC, among many others were 
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For recognizing pre-miRNAs in the virus genome, 
three machine learning (ML) methods were used: a 
deep convolutional neural network (CNN) [24], the 
deeSOM model  [25], and a one-class support 
vector machine (OC-SVM) [26,27]. The first 
method, CNN, was trained directly with raw RNA 
sequences (substrings of the complete genome), 
their corresponding predicted secondary structure 
and the MFE of the folding. The first layer of the 
network developed here is a one-dimensional 
convolution, followed by eight stacked identity 
blocks [28] and pooling layers. The identity blocks 
allow the model to auto-define the number of 
convolutional layers needed during training, 
avoiding optimization of this critical 
hyperparameter. The next layers concatenate the 
MFE and flatten the output, and finally a fully 
connected layer generates the score for the input 
sequence. 
The deeSOM model consists of several hierarchical 
layers with self-organizing maps (SOM) that has 
proven to be very suited to the pre-miRNA 
prediction task [25]. This model has an ensemble of 
unsupervised SOMs that are used in parallel at the 
first level. The unlabeled samples in the input data 
are split among the members of the ensemble, 
which also receive the full set of positive input 
cases. At each SOM layer, pre-miRNA neurons are 
identified as those having, at least, one positive 
sample. Only the sequences that are in pre-miRNA 
neurons pass to the next level. At each level, an 
adaptive algorithm determines the map size. 
Therefore, several deep layers are added with this 
self-size-adjusting method, until only known pre-
miRNA samples remain at the last layer. The best 
pre-miRNAs candidates are identified as the ones 
in the pre-miRNA neurons of the last levels. Finally, 
the OC-SV model is able to learn a decision frontier 
only from the well-known pre-miRNAs. SVM has 
been traditionally one of the most used machine 
learning models for pre-miRNA prediction [23]. 
Each method provided a list of candidate 
sequences corresponding to potential pre-miRNAs 
supported by a score. Potential pre-miRNAs were 
identified by considering predictions with scores in 
the top 10th percentile in all three methods.
2.3 PREDICTION OF MATURE MIRNAS AND 
TARGETS
Mature miRNA-like molecules definition was done 
combining MatureBayes predictions [29] with the 
exploration of the profiles of small RNA-seq reads 
in the regions covered by the predicted precursors. 
In this sense, in addition to considering that the 
reads profiles indicated the production of a miRNA-
like molecule, coverage higher than the mean was 
required. Moreover, since the protocol used for 
small RNA-seq could enrich polyA regions, miRNA-
like occurrences in non-rich polyA regions were 
verified. Potential targets in the host cells for the 
mature miRNAs were predicted combining Diana 
(MR-microT software) [30] and miRDB (Custom 
prediction option) [31]. In both cases, author 
recommendations were followed and only targets 
with scores over 70 were considered. A reliable set 
of targets was obtained keeping only those genes 
predicted using both Diana and miRDB tools.
2.4 DIFFERENTIAL EXPRESSION AND 
FUNCTIONAL ENRICHMENT ANALYSES
Expression matrices obtained from the bulk RNA-
seq of the Calu-3 cell cultures were analyzed with 
DESeq2 [32] for determining the set of differentially 
expressed genes (DEGs) as a response to the viral 
infection. Low expressed genes were discarded 
following DESeq2 manual suggestion and DEGs 
were detected using a false discovery rate (FDR) 
cutoff of 0.05, with a minimum value of 1 for the 
absolute log2 fold change. Three differential 
expression analyses were carried out for comparing 
infected and mock cultures at 24 hours upon 
infection (IM24), and for contrasting host gene 
expression at 12 and 24 hours upon infection 
against the respective samples at four hours (I12-4 
and I24-4, respectively). The lists of DEGs were 
then combined and the biological impact caused by 
those DEGs was evaluated by means of an 
overrepresentation analysis (ORA) of Gene 
Ontology terms using PANTHER and PANTHER 
GO-Slim Biological Process (BP) annotation sets 
[33,34]. Enrichment of metabolic pathways was 
also evaluated using both, PANTHER pathways 
and Reactome [34a] databases. Fisher exact tests 
with Bonferroni correction for multiple testing (cutoff 
0.05) were used taking all the genes with reliable 
expression after DESeq2 filtering as the reference 
list. The set of DEGs was also compared against 
the list of miRNA targets predicted in the host 
genome, identifying a list of DEGs targets. 
Additionally, the functionality of these genes was 
analyzed by an ORA but now considering the set of 
DEGs as the reference list. Enriched GO terms in 
BP PANTHER GO-Slim were found and targets 
DEGs responsible for those enrichments were 
explored. DEGs targets that were down-regulated 
in at least one comparison were detected and 
functionally characterized using PANTHER and the 
GOPlot R package [35].
2.5 MULTIPLE SEQUENCE ALIGNMENT
Multiple sequence alignment was performed for 
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genomes of the following coronaviruses: HKU1 
(NCBI Reference Sequence DQ415897.1), OC43 
(NCBI Reference Sequence KY983585.1), Bat-CoV 
RF1 (NCBI Reference Sequence DQ412042.1), 
Bat-CoV RATG13 (NCBI Reference Sequence 
MN996532.1), Malayan Pangolin (NCBI Reference 
Sequence MT072864.1), SARS-CoV (NCBI 
Reference Sequence AY278741.1), MERS-CoV 
(NCBI Reference Sequence MN120514.1), mice 
coronavirus (NCBI Reference Sequence GB 
KF294357.1) and ferret coronavirus (NCBI 
Reference Sequence 1264898). These alignments 
were performed with MUSCLE [36] from its web 
access with ClustalW type output format and default 
settings.
3. RESULTS
3.1 EIGHT POTENTIAL MATURE MIRNAS 
DERIVE FROM SIX PRECURSOR 
TRANSCRIPTS ENCODED IN THE SARS-COV-2 
GENOME
The identification of potential pre-miRNAs encoded 
in the SARS-CoV-2 genome was performed by 
three alternative computational approaches: a deep 
learning model (mirDNN), a deep self-organizing 
map with ensemble layers (deeSOM) and a one-
class support vector machine (OC-SVM) (details in 
2.2). Each method provided a list of candidate 
sequences corresponding to potential pre-miRNAs 
supported by a score. Considering predictions with 
scores in the top 10th percentile in all three 
methods, 12 highly reliable precursors were 
identified (Figure 1A, Supplementary File 1). The 
read profiles in the regions covered by these 
precursors were explored in the alignments of small 
RNA-seq samples from a recently released dataset 
(NCBI, Series GSE148729) involving SARS-CoV-2 
(USA-WA1/2020) infected cultures of the epithelial 
lung cancer cell line Calu-3. Those reads profiles 
were combined with MatureBayes [29] predictions 
for defining mature miRNAs-like sequences. Six of 
the reliable precursors that were predicted by 
machine learning techniques, all encoded in the 
positive strand of viral RNA (vRNA, Figure 1B), 
have shown to have a significant coverage in their 
respective miRNAs-like regions (Figure 1C, 
Supplementary File 2). Notably, two pre-miRNAs, 
SC2V-mir-M-3 and SCV-mir-ORF10, were 
predicted each to be processed into two alternative 
mature miRNAs, expanding the repertoire to eight 
miRNAs-like derived from vRNAs potentially 
regulating host genes (Supplementary File 3, 
examples of pre-miRNAs reads profiles and their 
predicted secondary structure are shown in Figure 
1C and Figure1D, respectively; details in 
Supplementary File 2). Analyzing the accumulation 
of mature miRNAs from the small RNA-Seq 
dataset, it was found that it follows the progression 
of the estimated viral content (Supplementary File 
4, panels A-B). Except for the SC2V-mir-ORF1ab-
1, detected only at 24 hours, all the pre-miRNAs 
were detected in Calu-3 infected samples at both 12 
and 24 hours upon infection, hinting at a differential 
timing of production of each mature miRNA 
throughout the infection cycle. 
A search for related human miRNAs deposited in 
miRBase was done based on the miRNA seed 
sequence [37], verifying that there is no significant 
similarity between predicted viral miRNAs and host 
miRNAs. Expanding the search for matching the 
identified miRNA-like molecules with miRNAs from 
any organism, only the SC2V-mir-M-1-5p was 
found to be similar to one miRNA from Drosophila 
Melanogaster (dme-miR-4982-3p, E-value 4.6). 
Then, to better understand what processes may 
affect this subset of SARS-CoV-2 miRNAs and 
assuming that they are acting as host genes 
regulators, human genes potentially targeted by 
them were identified. For obtaining a reliable set of 
candidate targets, two independent tools were 
used: Diana (MR-microT software) [30] and miRDB 
(custom prediction option) [31]. As recommended 
by the authors of Diana and miRDB, only predicted 
targets with a score over 70 were considered. In 
addition, only those genes identified as potential 
targets using the two algorithms were considered 
for further analyses. Overall, a total of 725 human 
genes were identified as potential targets of 
predicted SARS-CoV-2 miRNAs (Supplementary 
File 5). The number of potential targets ranges from 
one (SC2V-mir-M-3-3p) to 234 (SC2V-mir-
ORF1ab-1-3p) being 97 the average number of 
targets per mature miRNA (Figure 2A).
3.2 THE EXPRESSION PROFILE OF A SUBSET 
OF 109 POTENTIAL SARS-COV-2 MIRNA 
TARGETS IN THE HUMAN GENOME IS 
AFFECTED UPON INFECTION
It is known that miRNAs can modulate target mRNA 
stability or translation [38]. Thus, an assessment of 
the steady-state RNA levels of the subset of 
predicted target genes upon infection of cell 
cultures with SARS-CoV-2 was performed. To this 
end, the bulk RNA-seq expression matrix of the 
same samples of infected Calu-3 cell cultures used 
for identifying the set of reliable miRNAs was 
analyzed. Differential expression analyses were 
performed for comparing infected and mock 
cultures at 24 hours upon infection (IM24), and for 
contrasting host gene expression at 12 and 24 
hours upon infection versus the respective samples 
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on the statistical analysis of the provided 
expression data (see Methods), three lists of 
differentially expressed genes (DEGs) were 
determined. The number of DEGs found was 1,877 
for the IM24 contrast, 946 for the I12-4 comparison, 
and 1,955 for the I24-4. By joining these lists, a total 
of 2,663 deregulated genes were found, with nearly 
25% in common across the three subsets of DEG 
(Figure 2B). Notably, among the 2,663 DEGs, 1,802 
(over 67%) genes exhibited an upregulation upon 
infection. This suggests that the global modulation 
of the host transcriptome is not only the result of a 
massive transcriptional shutdown mediated by the 
viral non-structural protein 1 (Nsp1), an 
endonuclease capable of impairing host mRNA 
translation and promoting transcriptional 
degradation [38a, 38b, 38c].
For evaluating functional enrichment among DEGs, 
an overrepresentation analysis (ORA) was 
performed using PANTHER and the PANTHER 
GO-Slim Biological Process annotation set [33, 34]. 
Obtained results revealed that the three most 
enriched categories correspond to the type I 
interferon signaling pathway (GO:0060337), 
response to type I interferon (GO:0034340) and to 
the pyrimidine nucleobase catabolic process 
(GO:0006208), whereas the highest number of 
DEG in infected cells are grouped in the defense 
response term (GO:0006952). In addition, several 
GO terms also related to immune response 
(GO:0002456, GO:0030183, GO:0071621, 
GO:0072676, GO:0042100, GO:0042130,  
GO:0042742, GO:0050852) and specifics of the 
response to viral infection (GO:0051607) were 
underscored (Figure 2C). The enriched Reactome 
pathways found for DEG genes were seven, five of 
them related to signaling pathways (Interferon 
alpha/beta, R-HSA-909733.3; interferon gamma, R-
HSA-877300.3; Interleukin 10 R-HSA-6783783.3; 
Interleukin 4 and Interleukin 13, R-HSA-6785807.6; 
GPCR downstream, R-HSA-388396.6). The 
remaining two pathways are Chemokine receptors 
bind chemokines (R-HSA-380108.3) and 
Immunoregulatory interactions between a 
Lymphoid and a non-Lymphoid cell (R-HSA-
198933.6). Whereas, p53 (P00059) and apoptosis 
signaling (P00006) were the over-represented 
PANTHER pathways.
One hundred and nine DEGs (4.9%) were detected 
as potential target genes of six of the predicted 
SARS-CoV-2-derived miRNAs (Figure 3A). Thirty-
three of them were found as deregulated in all the 
evaluated contrasts, whereas 45 targets were 
uniquely identified in any of the three comparisons 
(Supplementary File 6). Within those genes, BIRC3 
[39,40], ACE2 [41], CXCL3 [42], JAK2 [43] and 
STAT2 [44,45], have been linked to the SARS-CoV-
2 infection. Twenty-eight of the 109 deregulated 
potential targets were significantly down-regulated 
in at least one of the comparisons evaluating 
changes caused by viral infection (Figure 3B). 
Except for SAMD13, potentially targeted by both 
SC2V-mir-ORF1ab-1-3p and SC2V-mir-ORF10-5p 
miRNAs, those genes were predicted as uniquely 
targeted by four of the predicted SARS-CoV-2-
derived miRNAs. Among the 28 genes, only three 
were down-regulated for the comparison I12-4, 
being two of them (RERG and NDRG1) identified 
as down-regulated in the other two comparisons 
too. In addition, seven genes were found silenced 
in cell cultures after 24 hours upon infection with 
respect to both, the mock samples at the same time 
and the infected samples after four hours of the 
infection. Moreover, 11 genes were uniquely found 
as significantly down-regulated for the comparison 
of infected and mock samples at 24 hours. 
Interestingly, the expression of 18 of these down-
regulated genes was found as anticorrelated with 
the potential miRNAs expression throughout time, 
i.e. mRNA levels decreased between 4h and 24h 
after infection (Supplementary File 4, panels B-F). 
The exploration of the functional annotations of 
those genes in PANTHER revealed that some of 
them participate in regulation processes, signaling 
pathways, and molecules binding, even having a 
catalytic activity (Figure 3C). ORA of DEG targets 
over all DEGs revealed a particular enrichment 
linked to the dendrite morphogenesis process and 
its regulation, as well as to neuronal development 
processes, potentially related to the neurological 
symptoms reported for COVID-19 patients [46] 
(Figure 3D). Among DEG targets that are down-
regulated, genes such as NTRK2, NAV1, ABHD2, 
ITGB6, PKIB, and ADSSL1 are annotated in the 
deregulated GO terms. Strikingly, three of these 
down-regulated target genes (ITGB6, PDK1, and 
ST6GALNAC2) have been linked to the response to 
SARS-CoV infections [47-49]. Collectively, our 
analyses indicate that multiple miRNAs-like 
predicted from the SARS-CoV-2 genome may 
dynamically modulate the host transcriptome upon 
infection.
3.3 SARS-COV-2 PREDICTED MIRNA-LIKE 
SMALL RNAS ARE A DISTINCTIVE FEATURE 
RECENTLY ACQUIRED IN COMPARISON WITH 
RELATED CORONAVIRUSES
Remarkably, the six pre-miRNAs derived from the 
SARS-CoV-2 genome coincide with ORFs and 
overlap with protein-coding genes (Figure 1B). 
Thus, evolutionary pressure exerted by the 
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restrict the variability of miRNA precursors. 
Therefore, for assessing miRNA variability across 
related genomes, the corresponding regions of the 
predicted pre-miRNAs were examined in other 
coronaviruses infecting several organisms: 
bat, pangolin, human, mice and ferret. No related 
sequences were retrieved by sequence identity 
searches in other human Betacoronaviruses 
genomes associated with mild symptoms, such as 
HKU1 (DQ415897.1) and OC43 (KY983585.1) [50]. 
The comparison with two bat (Rhinolophus affinis) 
coronaviruses RATG13 (MN996532.1) and RF1 
(DQ412042.1), the Malayan Pangolin (Manis 
javanica) coronavirus (MT072864.1) and human 
SARS-CoV (AY278741.1) revealed that most of the 
predicted mature miRNAs were recently acquired 
with no or low impact on the corresponding coding 
capacity of overlapping ORFs. With mice (GB 
KF294357.1) and ferret (ID 1264898) 
coronaviruses, no significant conservation of the 
mature miRNAs across species was found. Overall, 
sequence alignment results indicated that the 
predicted mature miRNAs from the SARS-CoV-2 
genome are more conserved in the RATG13 than 
in the Pangolin-CoV (Figure 4A, and two examples 
given in Figure 4B; details in Supplementary File 7). 
Notably, none of the identified mutations between 
RATG13 and SARS-CoV-2 resulted in an amino-
acid substitution of the overlapped protein-coding 
genes, although punctual mutations were found in 
the seed sequence of three predicted mature 
miRNAs, likely affecting the recognition of target 
host mRNAs. Similarly, seven out of the eight 
miRNA-likes exhibit changes between SARS-CoV-
2 and Pangolin-CoV, including four miRNAs with 
changes in the seed sequence. Remarkably, only 
one predicted miRNA (SC2V-mir-ORF1ab-1-3p) 
includes a mutation altering the related protein-
coding sequence. Nearly all the predicted miRNAs 
exhibit differences in the RF1 and SARS-CoV 
genomes, including six cases with altered seeds 
sequences, respectively. Remarkably, only two 
miRNAs suffered changes in the overlapping 
encoded protein in each of these two latest 
genomes, being SC2V-mir-ORF1ab-2-5p the least 
conserved across all genomes assessed (Figure 4). 
Altogether, our results suggest that, if their function 
is verified, the acquisition of predicted novel 
miRNAs potentially targeting human genes may 
constitute a genome feature that permitted or 
helped SARS-CoV-2 progenitors to jump inter-
species boundaries to infect humans.
4. DISCUSSION
The presence of numerous miRNAs in viral 
genomes has been previously described [11]. 
Although most of them were found in genomes of 
nuclear-replicating DNA viruses and in retroviral 
genomes, in recent years the existence of miRNA-
like sequences has been described in genomes of 
RNA viruses that replicate in the cytoplasm, such 
as Ebola [51,52], dengue-2 [15], hepatitis A [53] and 
West Nile [54]. Their functionality is still a matter of 
debate. It has been speculated that the miRNAs 
encoded into viral RNA genomes could modulate 
the expression of host genes involved in the 
antiviral response [51,52] as well as of the own viral 
genes. Thus it can be stated that they are 
contributing to the regulation of the replication cycle 
[15,53,54]. Interestingly, it was recently reported 
that three small RNAs encoded into the SARS-CoV-
1 genome are functional and play a role in lung 
pathology [16]. The mechanisms involved in the 
biogenesis of miRNAs from the RNA virus genomes 
whose replication is confined into the cytoplasm 
remain unclear, as the vRNA could not have access 
to the nuclear enzymatic complex necessary to 
initiate the canonical process of miRNA generation 
[12,55]. Notably, some proteins encoded in 
coronavirus genomes could be involved, directly or 
indirectly, in the cytoplasmic production of viral 
miRNAs. Among them, Nsp15 (EndoU) has a 
demonstrated activity as endoribonuclease, and it 
was shown that EndoU-deficient CoVs are highly 
attenuated [56]. Although it was proposed that 
EndoU may target vRNA [57], its potential role in 
the biogenesis of functional svRNAs remains 
unexplored. Besides, the Nsp1 protein, which also 
has the ability to induce cytoplasmic 
endonucleolytic activity and participates in the 
transcriptional shutdown of host mRNAs [58,59, 
59a], causes disruption of the nuclear pore [60], that 
could be associated with the eventual relocation of 
targets or enzymes necessary for the coronavirus 
miRNA biogenesis process. 
In humans, most miRNA genes are located in 
intergenic or intronic regions. However, several 
miRNA genes have also been found in exons and 
intron-exon junctions [61-63]. It has been proposed 
that the processing of exon-encoded pre-miRNAs 
could serve to destabilize the parent gene transcript 
[64]. Combining machine learning approaches and 
small RNA-seq data analysis, we identified six 
precursors of eight potentially active miRNAs in the 
SARS-CoV-2 genome. We found that all the 
predicted pre-miRNAs are overlapped to protein-
coding genes. In agreement with the observations 
made in humans, it has been suggested that the 
processing of miRNA encoded in an RNA virus 
would destroy the parent genome, or replicative 
intermediates, conspiring against its own replication 
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et al. (2010), less than 1% of the synthesized viral 
genome in cells infected with the flavivirus TBEV is 
needed to generate a functional amount of miRNAs, 
and therefore the productivity of the viral replication 
would be only marginally affected by the generation 
of miRNAs.
We found that several genes predicted as targets of 
our miRNA candidates were transcriptionally 
deregulated upon infection. It was proposed that 
between 10% and nearly 40% of human miRNA 
target genes are impaired in translation without 
altering RNA steady-state levels [65], suggesting 
that the effect of several viral miRNAs upon their 
host targets could remain undetectable by RNA-
Seq approaches. Remarkably, among DEG targets 
we found 81 genes upregulated upon infection for 
at least one of the comparisons between the time-
points assessed. For miRNAs blocking mRNA 
translation, this could be the result of negative 
feedback regulatory loops exerted by proteins over 
the transcription of their parent genes. Alternatively, 
this may indicate that viral miRNAs would be 
produced in different phases of the viral replication 
cycle, or depending on the viral charge in the cell, 
likely triggering post-transcriptional gene silencing 
under specific circumstances. A better 
understanding of miRNA biogenesis throughout the 
infection may allow the use of circulating viral 
miRNAs as biomarkers of the progression of the 
associated disease [66].
Interestingly, 28 genes potentially targeted by 
predicted SARS-CoV-2 miRNAs resulted down-
regulated upon infection (Figure 3B). Remarkably, 
three down-regulated genes have been linked to 
SARS-CoV infection. The first one of them, 
ST6GALNAC2, encodes a sialyltransferase and its 
transcriptional accumulation was found highly 
associated with SARS pathogenesis [49]. The 
second one gene, ITGB6, encodes an integrin first 
linked to the infection by herpes simplex virus [67]. 
It has been recently found that the expression of 
ITGB6 may be modulated by SARS-CoV-2 infection 
of human myocardium [47]. Notably, the induction 
of ITGB6 by TFGβ was proposed to be related with 
pulmonary fibrosis [68], whereas genetic variants in 
this gene have been associated with the risk of 
pneumonitis in lung cancer patients treated with 
thoracic radiation therapy [69]. Furthermore, it has 
been suggested that ITGB6 participates in 
cytomegalovirus-associated pneumonia [70]. The 
third coronavirus-related downregulated target is 
PDK1. Strikingly, SARS-CoV-1 membrane protein 
M induces apoptosis via interfering with the kinase 
PDK1 [48]. Here we showed that the M-locus 
derived miRNA, SC2V-mir-M-1-5p, would be able to 
target PDK1 mRNA, whose accumulation 
significantly decreases upon infection (Figure 3B). 
Interestingly, the over-expression of the M protein 
in transgenic Drosophila has been shown to trigger 
mitochondrial-mediated apoptosis, together with 
the down-regulation of Akt protein phosphorylation 
in a PDK1-dependent manner. However, PDK1 
transcript levels were not quantified in M-
expressing flies [71]. Our findings suggest that the 
M transgene would potentially produce active 
miRNAs against endogenous PDK1 transcripts, 
thus affecting the PDK1-Akt survival pathway. 
Notably, the progression of different tumors, 
including non-small cell lung cancer, has been 
associated with the activity of several human 
endogenous miRNAs targeting PDK1 [72-74], 
hinting at general post-transcriptional regulation of 
the PDK1 gene expression in disease.  
Additionally, 19 of the 28 down-regulated target 
genes have been previously linked to respiratory 
diseases, whereas eight have been related to the 
response to virus, being seven genes in common. 
ABHD2 participates in virus propagation and the 
modulation of the immune response, for which it 
was identified as a potential target of anti-hepatitis 
B drugs [75]. Interestingly, genetic variations in this 
gene have been associated with obstructive 
pulmonary disease in a Chinese Han population 
and age-related pulmonary emphysema in mice 
[76]. Moreover, the expression of ABHD2 was 
identified as a discriminating feature between 
smokers and non-smokers [77]. The deregulation of 
the tumor suppressor NDRG1 has been associated 
with the progression of lung cancer [78]. Strikingly, 
infection by Merkel Cell Polyomavirus leads to 
NDRG1 down-regulation and cellular proliferation 
and migration [79]. Further, the Porcine 
Reproductive and Respiratory Syndrome virus was 
found to facilitate viral replication through the down-
regulation of NDRG1 [80]. It was also suggested 
that this gene plays an important role in the 
epithelial physical barrier defects in chronic 
rhinosinusitis [81]. Notably, NDRG1 is subjected to 
post-transcriptional gene silencing upon Influenza A 
infection [82]. The RNA stability of the chromatin-
related gene CBX5/HP1 has also been linked to the 
inflammatory response and apoptosis [83]. The 
chromatin disorganization suffered upon CBX5 
deregulation has been proposed to modulate lung 
tumor progression [84] as well as the infection by 
HIV [85-87]. In addition, the transcript levels of the 
FUT9 gene encoding a fucosyltransferase have 
been associated with the modulation of the immune 
response to pathogens [88] and the progression to 
apoptosis [89]. Remarkably, it has been shown that 
the intraperitoneal administration of FUT9 in 
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bronchopulmonary dysplasia, resulting in significant 
decrease in inflammation, alveolar-capillary 
leakage, alveolar simplification, and cell death [90]. 
The gene NBEA has been related to oropharyngeal 
carcinoma [91], and RERG behavior was 
considered a biomarker in nasopharyngeal Epstein-
Barr virus-associated carcinoma [92]. Further 
potential SARS-CoV-2 miRNA targets were found 
implicated in lung development (DNAJC22, [93]) 
and function (CTSH, [94], and in the progression of 
lung cancer and disease (NTRK2, [95]; SYT7, 
[96,97]; TMEM106B, [98,99]; PKIB, [100]). 
Several of the above-mentioned genes have been 
demonstrated to be regulated by human miRNAs. 
ABHD2 encodes a serine hydrolase whose 
regulation by endogenous miRNAs may contribute 
to the progression of different tumors [101,102]. 
REPS2, involved in esophageal carcinoma [103] 
and apoptosis [104], is regulated by an endogenous 
miRNA enhancing tumorigenesis. Also, the miRNA-
mediated regulation of LZTS3 expression promotes 
lung cancer cell proliferation and metastasis [105]. 
Interestingly, we showed here that the SC2V-mir-
ORF1ab-1-3p miRNA likely targets the VAV3 
circular RNA (circRNA). CircRNAs are highly stable 
covalently bound circular molecules capable of 
sequestering miRNAs, among other regulatory 
functions. Furthermore, several circRNAs have 
been related to antiviral immunity [106]. It was 
shown that the interplay between VAV3 circRNA 
and associated miRNAs can modulate the 
progression of lung tumors in humans [107]. 
Moreover, chicken VAV3 sponges gga-miR-375 
promoting the epithelial-mesenchymal transition 
[108]. Notably, it was proposed that gga-miR-375 
plays a key role in tumorigenesis post avian 
leukosis virus infection in chicken [109]. Finally, it is 
worth mentioning that the SARS-CoV-2 potential 
target LTBP1 is regulated by the human miRNA-
155, activating the expression of downstream 
oncogenes and repressing the TGF-β signaling 
pathway [110]. Strikingly, it was shown that the 
double-stranded DNA virus causing Marek's 
disease encodes an analog of miR-155. The viral 
miRNA promotes the proliferation of chicken 
embryo fibroblasts by targeting endogenous 
mRNAs [111]. Collectively, our observations 
suggest that SARS-CoV-2-derived miRNA-like 
sequences may modulate the host transcriptome 
promoting the infection progression. 
Although several efforts are being carried out to 
prove the origin of the SARS-CoV-2, it is a matter 
still under debate. A comparison with closely related 
coronaviruses served to propose the bat 
Rhinolophus affinis and the pangolin Manis 
javanica as potential reservoir hosts of SARS-CoV-
2 progenitors [112, 113]. However, the divergences 
detected here between the predicted mature 
miRNAs of SARS-CoV-2 and Pangolin CoV seem 
to support other evidences that deny the role of the 
latter as a direct ancestor of the former [114]. The 
identification of punctual mutations in the Spike 
receptor-binding domain from these coronaviruses 
served to explain the SARS-CoV-2 improved 
binding to the human cell receptor ACE2 and its 
rapid human-to-human transmission [115], whereas 
changes in their structure due to post-translational 
modifications have been recently linked to 
differential protein stability and interaction with the 
host receptors [116]. Here, we identified a group of 
accumulated punctual mutations, many of which do 
not alter the corresponding encoded proteins, 
notably between RATG13 and SARS-CoV-2, albeit 
affecting the potential activity of the novel derived 
miRNAs in the modulation of the human 
transcriptome. Thus, these genomic variations may 
have contributed to this or another as yet unknown 
ancestor towards overcoming the barriers between 
species and acquiring the ability to replicate in 
humans. Notably, it has been shown that a variety 
of model organisms and cell lines exhibit a 
differential susceptibility to SARS-CoV-2 [117,118]. 
Although it has been proposed that these 
differences are likely dependent on species specific 
make-up for ACE2 [119], we cannot exclude that 
the emergence of novel active miRNAs derived 
from the viral genome may participate in the host-
virus interplay restricting the range of susceptible 
animals. 
The international scientific community is devoting 
enormous efforts to cope with COVID-19. The 
experimental validation of the activity of these 
potential miRNA encoding genes, their role in the 
recent evolution of SARS-CoV-2, and their 
underlying molecular mechanisms will likely help to 
push back the frontiers of human therapeutics in the 
context of the actual sanitary crisis worldwide.
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Figure 1: Identification of potential miRNA from six precursors hidden in the protein-coding genome of 
SARS-CoV-2. A) Venn diagram showing the number of candidate sequences to pre-miRNAs in the SARS-
CoV-2 virus found by three machine learning methods: deeSOM (blue), mirDNN (orange) and OC-SVM 
(green). Deep models are schematically represented. On top is the deeSOM, several layers with ensembles 
of self-organizing maps, with elastic map size and automatic depth. On bottom is the mirDNN, a novel 
convolutional neural network with several layers and identity blocks. B) Genome location of the six predicted 
pre-miRNAs in the SARS-CoV-2 virus. C) Two examples of the read profiles in small RNA-seq samples of 
Calu-3 cell cultures at 24 hours upon infection. The horizontal blue line indicates the average reads counts 
for the whole genome. D) Predicted hairpin structures of the two SARS-CoV-2 pre-miRNAs shown in C).
Figure 2: Predicted viral miRNA targets in the human genome and differentially expressed genes upon 
infection. A) Number of targets predicted for each SARS-CoV-2 miRNA candidate. Colors indicate the 
corresponding pre-miRNA. B) Venn diagram of differential expression results from RNA-seq experiments 
of Calu-3 cell cultures infected by SARS-CoV-2. Performed tests compared: i) Infected (I) versus mock (M) 
samples at 24 hours upon infection; ii) Infected samples at 4 and 12 hours upon infection; iii) Infected 
samples at 4 and 24 hours upon infection. C) Enrichment results for the top 30th terms of the Biological 
Process PANTHER GO-Slim caused by differentially expressed genes (DEGs). Terms are grouped based 
on the ontology hierarchy being the term in bold the deepest.
Figure 3: A subset of potential SARS-CoV-2 miRNA targets deregulated upon infection are related to 
specific biological and molecular functions. A) Number of targets predicted for each SARS-CoV-2 miRNA 
candidate that were detected as differentially expressed genes (DEGs) in RNA-seq experiments of Calu-3 
cultures infected with the virus. Colors indicate the corresponding pre-miRNA. B) Fold change, in log-2 
scale, of those predicted SARS-CoV-2 miRNAs targets that were detected as down-regulated in at least 
one of the contrasts evaluated. Marks indicate significant changes. C) GOChord plot showing Biological 
Process (BP) and Molecular Function (MF) GO terms of the targets DEGs down-regulated. D) Enrichment 
results for the overrepresentation analysis of targets DEGs over all the DEGs. Only those BP PANTHER 
GO-Slim terms with enrichment scores higher than 4.2 (average enrichment score) are shown. Terms are 
grouped based on the ontology hierarchy being the term in bold the deepest.
Figure 4: Punctual mutations detected across related coronaviruses hint at the acquisition of potential 
mature miRNAs targeting human genes. A) Graphical representation of alignment results of the predicted 
miRNAs in SARS-CoV-2 along with several coronaviruses genomes. Each box contains the number of 
changes detected in the genomic sequence of a particular miRNA and the number of changes detected in 
the sequence of the overlapping protein. The color of each box indicates the number of changes in the 
genomic sequence of the miRNA that are in its seed. B) Two examples of the alignment results of predicted 
miRNAs in SARS-CoV-2 against other coronaviruses. Positions corresponding to miRNAs seeds are 
marked and highlighted boxes represent mismatches. C) Illustration of the changes in the corresponding 
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response to biotic stimulus (GO:0009607)
response to external biotic stimulus (GO:0043207)
response to other organism (GO:0051707)
defense response to other organism (GO:0098542)
innate immune response (GO:0045087)
type I interferon signaling pathway (GO:0060337)
response to type I interferon (GO:0034340)
pyrimidine nucleobase catabolic process (GO:0006208)
immune effector process (GO:0002252)
defense response to virus (GO:0051607)
response to virus (GO:0009615)
lymphocyte mediated immunity (GO:0002449)
T cell mediated immunity (GO:0002456)
response to cadmium ion (GO:0046686)
cellular response to chemokine (GO:1990869)
response to chemokine (GO:1990868)
chemokine−mediated signaling pathway (GO:0070098)
B cell differentiation (GO:0030183)




response to interleukin−1 (GO:0070555)
positive regulation of ERK1 and ERK2 cascade (GO:0070374)
B cell proliferation (GO:0042100)
negative regulation of T cell proliferation (GO:0042130)
defense response to bacterium (GO:0042742)
regulation of epithelial cell differentiation (GO:0030856)
defense response (GO:0006952)
T cell receptor signaling pathway (GO:0050852)























































































































































Negative regulation of molecular function














































































































































































Contrast I12−4 I24−4 IM24
regulation of neuron projection development (GO:0010975)
regulation of plasma membrane bounded cell projection organization (GO:0120035)
regulation of cell projection organization (GO:0031344)
regulation of neuron differentiation (GO:0045664)
regulation of nervous system development (GO:0051960)
regulation of cell development (GO:0060284)
regulation of neurogenesis (GO:0050767)
regulation of anatomical structure morphogenesis (GO:0022603)
regulation of cell morphogenesis involved in differentiation (GO:0010769)
regulation of cell morphogenesis (GO:0022604)
regulation of dendrite morphogenesis (GO:0048814)
regulation of dendrite development (GO:0050773)
dendrite morphogenesis (GO:0048813)
dendrite development (GO:0016358)
integrin−mediated signaling pathway (GO:0007229)
regulation of catabolic process (GO:0009894)
regulation of protein catabolic process (GO:0042176)
regulation of proteasomal ubiquitin−dependent protein catabolic process (GO:0032434)
developmental growth (GO:0048589)
growth (GO:0040007)

























































RATG13 PANGOLIN−CoV RF1 SARS−CoV
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